Nathan J Dowden

President & COO, Entrada Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.4M

Companies

Latest trade

May 4, 2026

Companies

Entrada Therapeutics, Inc.President & COO −$0.4M

Trades

TRDA Sold 15,000 shares at $15.33 · planned $0.2M May 4

TRDA Sold 11,894 shares at $13.05 · planned $0.2M Mar 10

TRDA Sold 3,116 shares at $13.02 · planned $0.0M Mar 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.